GENETIC CONSTRUCT AND USES THEREOF
20220213491 · 2022-07-07
Inventors
- Nigel Minton (Nottingham, GB)
- Ines Canadas Blasco (Nottingham, GB)
- Daphne Groothuis (Nottingham, GB)
- Maria Zygouropoulou (Nottingham, GB)
Cpc classification
A61K35/742
HUMAN NECESSITIES
C12N15/67
CHEMISTRY; METALLURGY
Y02A50/30
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
C12N15/63
CHEMISTRY; METALLURGY
International classification
C12N15/67
CHEMISTRY; METALLURGY
A61K35/742
HUMAN NECESSITIES
Abstract
A spore-forming cell comprising a first nucleotide sequence encoding a riboswitch and a transcriptional activator, wherein the riboswitch modulates translation of the transcriptional activator in response to a First inducer, and a second nucleotide sequence encoding a target gene that regulates spore formation, wherein the target gene is expressed in response to a second inducer and translation of the transcriptional activator. Also provided is a method of culturing a spore-forming cell and a method of creating a spore, as well as uses of spore-forming cells and spores.
Claims
1. A spore-forming cell comprising a first nucleotide sequence encoding a riboswitch and a transcriptional activator, wherein the riboswitch modulates translation of the transcriptional activator in response to a first inducer, and a second nucleotide sequence encoding a target gene that regulates spore formation, wherein the target gene is expressed in response to a second inducer and translation of the transcriptional activator.
2. The spore-forming cell according to claim 1, wherein the spore-forming cell is a synthetic biological cell, a bacterium, a plant, an algae, a fungi or a protozoa.
3. The spore-forming cell according to claim 2, wherein the bacterium is a species selected from the group consisting of C. acetobutylicum, C. aerotolerans, C. autoethanogenum, C. baratii, C. beijerinckii, C. bifermentans, C. botulinum, C. butyricum, C. cadaveris, C. cellulolyticum, C. cellulovorans, C. chauvoei, C. clostridioforme, C. colicanis, C. difficile (now renamed Clostridioides difficile), C. estertheticum, C. fallax, C. feseri, C. formicaceticum, C. histolyticum, C. innocuum, C. kluyveri, C. ljungdahlii, C. lavalense, C. novyi, C. oedematiens, C. paraputrificum, C. pasteurianum, C. perfringens, C. phytofermentans, C. piliforme, C. ragsdalei, C. ramosum, C. roseum, C. saccharoperbutylacetonicum, C. scatologenes, C. septicum, C. sordellii, C. sporogenes, C. sticklandii, C. tertium, C. tetani, C. thermocellum, C. thermosaccharolyticum, C. tyrobutyricum, C. paprosolvens, C. saccharobutylicum, C. carboxidovorans, C. scindens, or C. autoethanogenum.
4. The spore-forming cell according to any one of the preceding claims, wherein the riboswitch comprises or consists of an aptamer domain, which is capable of specifically binding to an inducer, and an expression platform, which undergoes a conformational change (in response to the binding of the inducer to the aptamer domain) that promotes translation of the transcriptional activator.
5. The spore-forming cell according to any one of the preceding claims, wherein the riboswitch modulates translation of a transcriptional activator in response to contact of the aptamer domain with a (first) inducer, preferably the riboswitch modulates translation of the transcriptional activator, in response to contact with an inducer, by positively regulating translation or transcription of the transcriptional activator.
6. The spore-forming cell according to claim 4 or claim 5, wherein the aptamer domain of the riboswitch specifically binds the (first) inducer.
7. The spore-forming cell according to claim 6, wherein the nucleotide sequence encoding the riboswitch is substantially as set out in SEQ ID NO. 3, 4, 5, 6, 7, 8 or 9, or a variant or fragment thereof.
8. The spore-forming cell according to any one of the preceding claims, wherein the (first) inducer is theophylline.
9. The spore-forming cell according to any one of the preceding claims, wherein the second inducer is lactose.
10. The spore-forming cell according to any one of the preceding claims, wherein the transcriptional activator is the transcription factor, BgaR.
11. The spore-forming cell according to claim 10, wherein the nucleotide sequence encoding the transcriptional activator is substantially as set out in SEQ ID NO. 10, or a variant or fragment thereof.
12. The spore-forming cell according to claim 10 or 11, wherein the second nucleotide sequence encodes a DNA-binding site of BgaR that is substantially as set out in SEQ ID NO. 11, or a variant or fragment thereof.
13. The spore-forming cell according to any one of the preceding claims, wherein the target gene is a gene that controls sporulation, preferably in bacteria.
14. The spore-forming cell according to any one of the preceding claims, wherein the spore-forming cell is only able to sporulate in the presence of the first and/or the second inducer.
15. The spore-forming cell according to any one of the preceding claims, wherein the target gene is spo0A.
16. The spore-forming cell according to any one of the preceding claims, wherein the target gene is encoded by a nucleotide sequence substantially as set out in SEQ ID NO. 12, or a variant or fragment thereof.
17. The spore-forming cell according to any one of the preceding claims, wherein the first nucleotide sequence and the second nucleotide sequence are encoded by at least one genetic construct.
18. A method of culturing a spore-forming cell, the method comprising culturing the spore-forming cell according to any one of claims 1 to 17 in the absence of a first and/or second inducer.
19. The method according to claim 18, wherein the spore-forming cell is contacted with a first inducer and a second inducer in order to induce the formation of a spore.
20. A method of creating a spore, the method comprising contacting the spore-forming cell of any one of claims 1 to 18 with a first inducer and a second inducer.
21. A spore obtained or obtainable from a method according to claim 20.
22. A spore-forming cell according to any one of claims 1 to 18 or a spore according to claim 21 for use in therapy.
23. A spore-forming cell according to any one of claims 1 to 18 or a spore according to claim 21 for use in treating or preventing treating diseases and disorders associated with the gut microbiome, such as a C. difficile infection (CDI), Irritable Bowel Disease (IBD), or cancer (bowel cancer).
24. A spore-forming cell according to any one of claims 1 to 18 or a spore according to claim 21 for use in treating or preventing a solid tumour.
25. A spore-forming cell according to any one of claims 1 to 18 for use in preventing the contamination of production facilities with spores during the manufacture from Clostridium of a biochemical, protein or other commercial product.
26. A riboswitch having positive regulatory activity.
27. The riboswitch according to claim 26, wherein a riboswitch having positive regulatory activity comprises a nucleotide sequence substantially as set out in SEQ ID NO. 3, 4, 5, 6, 7, 8 or 9, or a variant or fragment thereof.
28. A genetic construct comprising or consisting of a riboswitch according claim 26 or 27.
29. A genetic construct comprising or consisting of a nucleotide sequence encoding a riboswitch and a transcriptional activator, wherein the riboswitch modulates translation of the transcriptional activator in response to an inducer and the transcriptional activator promotes transcription of a target gene.
30. At least one genetic construct comprising or consisting of: a first nucleotide sequence encoding a riboswitch and a transcriptional activator, wherein the riboswitch modulates translation of the transcriptional activator in response to a first inducer, and a second nucleotide sequence encoding a target gene, wherein the target gene is expressed in response to a second inducer and translation of the transcriptional activator.
31. A genetic construct according to claim 29 or 30, wherein the genetic construct is capable of reducing ‘leakiness’ (i.e. basal transcription and/or translation of a target gene) by at least 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80% or 90%.
32. A vector comprising a genetic construct according to claim 29, 30 or 31.
33. A host cell comprising a genetic construct according to claim 29, 30 or 31 or a vector according to claim 32.
34. A method of inducing translation, in a cell, of an RNA molecule encoding a (first) nucleotide sequence, the method comprising: transforming a host cell with a genetic construct according to claim 29, 30 or 31 or a vector according to claim 32 to create a transformed host cell; and contacting the transformed host cell with a (first) inducer to induce translation of the RNA of the (first) nucleotide sequence.
35. A method of inducing expression, in a cell, of a target gene, the method comprising: transforming a host cell with a genetic construct according to claim 29, 30 or 31 or a vector according to claim 32 to create a transformed host cell; and contacting the transformed host cell with a first inducer and a second inducer to induce expression of the target gene in the transformed host cell.
Description
[0123] For a better understanding of the invention, and to show how embodiments of the same may be carried into effect, reference will now be made, by way of example, to the accompanying Figures, in which:—
[0124]
[0125]
[0126]
[0127]
[0128]
[0129]
[0130]
[0131]
[0132]
[0133]
[0134]
[0135]
[0136]
[0137]
[0138]
[0139]
[0140]
[0141]
[0142]
[0143]
[0144]
[0145]
[0146]
[0147]
[0148]
[0149]
[0150]
[0151]
[0152]
[0153]
[0154]
[0155]
[0156]
[0157]
[0158]
[0159]
EXAMPLES
Materials and Methods
Strains, Media and Growth Conditions.
[0160] All the E. coli and Clostridium strains used in this application are listed in Table 2. E. coli TOP C (Invitrogen) was used as a general host for plasmid construction and propagation. E. coli CA434 was used as the donor strain for conjugation. All E. coli strains were transformed through electroporation using a MicroPulser™ system (BioRad). E. coli strains were grown at 30 or 37° C., in Luria-Bertani (LB) medium supplemented with chloramphenicol (25 μg/mL in solid and 12.5 μg/mL in liquid media), erythromycin (500 μg/mL) or kanamycin (50 μg/mL) when necessary. Media for clostridial strains were supplemented with the following antibiotic/inducer/supplement when appropriate: thiamphenicol (15 μg/mL), erythromycin (10 μg/mL), D-cycloserine (500 μg/mL), theophylline (0.1-10 mM), glucose 0.05% w/v. Clostridium strains were grown at 37° C. in an anaerobic cabinet (MG1000 anaerobic workstation; Don Whitley Scientific Ltd).
TABLE-US-00008 TABLE 2 Strain Source.sup.b C. sporogenes NCIMB 10696 CRG C. sporogenes pyrE.sup.− [*] C. sporogenes::LAC This application C. sporogenes::RiboLac This application C. sporogenes pyrE.sup.− Δspo0A This application C. sporogenes Δspo0A This application C. sporogenes Δspo0A.sup.COMP This application C. sporogenes Δspo0A::P.sub.fdx4-E-spo0A This application C. sporogenes Δspo0A::P.sub.fdx4*-E-spo0A This application C. sporogenes Δspo0A::P.sub.fdx-E-spo0A This application C. sporogenes Δspo0A::P.sub.fdx-G-spo0A This application C. sporogenes Δspo0A::P.sub.fdx*-E-spo0A This application C. sporogenes Δspo0A::P.sub.fdx*-G-spo0A This application C. sporogenes Δspo0A::P.sub.araE*-E-spo0A This application C. sporogenes Δspo0A::P.sub.araE*-G-spo0A This application C. sporogenes Δspo0A::LAC-spo0A This application C. sporogenes Δspo0A::RiboLac-spo0A This application *Heap, J. T. et al. Integration of DNA into bacterial chromosomes from plasmids without a counter-selection marker. Nucleic Acids Res. 40, e59 (2012)
Reagents.
[0161] All PCR reactions were performed using KOD-Hot Start Polymerase 2× Master Mix (Merck Millipore) or DreamTaq Green PCR Master Mix (Thermo Fisher Scientific). T4 ligase (Promega) was used for DNA ligation reactions. Restriction enzymes were purchased from New England Biolabs. Theophylline was purchased from Sigma-Aldrich.
Plasmid Design, Construction and Transformation.
[0162] Oligonucleotide primers were synthesized by Sigma-Aldrich and are listed in Table 4. Plasmids were constructed by restriction enzyme-based cloning procedures. Constructs were verified by DNA sequencing (Eurofins). All the plasmids used in this study are listed in Table 3. Details of plasmid construction are given in the Supporting Information. Protospacer sequences were designed according to the protocol described at http://benchling.com/pub/ellis-crspr-tools.
TABLE-US-00009 TABLE 3 Plasmid Reference source pMTL82251 [*] pMTL83151 [*] pMTL-HZ1 Wang, H. CRG pMTL-IC001 This application pMTL-IC1201 This application pMTL-ICMO1 This application pMTL-ICMO2 This application pMTL-ICMO1O2 This application pMTL-ICMB This application pMTL-ICT1 This application pMTL-ICT2 This application pMTL-ICT3 This application pMTL-ICT4 This application pMTL-ICT5 This application pMTL-ICT6 This application pMTL-ICT7 This application pMTL-ICT8 This application pMTL-ICT9 This application pMTL-ICT10 This application pMTL-ICT11 This application pMTL-ICM1 This application pMTL-ICM2 This application pMTL-ICM3 This application pMTL-ICM4 This application pMTL-ICM5 This application pMTL-ICM6 This application pMTL-ICM7 This application pMTL-ICM8 This application pMTL-ICM9 This application pMTL-ICM10 This application pMTL-ICM11 This application pMTL-IC101 This application pMTL-IC111-D This application pMTL-IC111-E This application pMTL-IC111-E* This application pMTL-IC111-F This application pMTL-IC111-G This application pMTL-IC111-H This application pMTL-IC111-I This application pMTL-IC111-J This application pMTL-IC121-E This application pMTL-IC121-G This application pMTL-IC121-H This application pMTL-IC201 This application pMTL-IC201-E This application pMTL-IC201-G This application pMTL-IC201-H This application pMTL-IC221-E This application pMTL-IC221-G This application pMTL-IC221-H This application pMTL-ICE1 This application pMTL-ICG1 This application pMTL-ICH1 This application pMTL-ICE1* This application pMTL-ICG1* This application pMTL-ICH1* This application pMTL-JH29 [**] pMTL-JH29T This application pMTL-JH29T-L This application pMTL-JH29T-R This application pMTL-ICLG1* This application pMTL-ICLH1* This application *Heap, J. T., Pennington, O. J., Cartman, S. T. & Minton, N. P. A modular system for Clostridium shuttle plasmids. J. Microbiol. Methods 78, 79-85 (2009). **Heap, J. T. et al. Integration of DNA into bacterial chromosomes from plasmids without a counter-selection marker. Nucleic Acids Res. 40, e59 (2012)
TABLE-US-00010 TABLE 4 SEQ ID No. Primer Sequence 14 IC103-f TATAGGTCTCAATGGTATTTGAAAAAAT 15 IC104-r TATACTCGAGTTAACTATTTATCAATTCCTG 16 IC105-f CAGCGGCCGCATGGTATTTGAAAAAATTGATAAAAA 18 IC301-f TATAGCGGCCGCAAATATTCTTATATTTAGA 19 IC302-r TATAGGTCTCACCATTTCTACCTCCTA 20 IC303-f AAAGCAGTTTATTTAAAATAAATTCTTCTAAATATAAGAATATTTTAAAGAAATATCTTT 21 IC304-r TATTTTAAATAAACTGCTTTGCAAAGCTCTCATGT 22 IC305-f TTATAAGATTATATAGAACTTTTTAACTATTCTAAAAGATTAATTTACATA 23 IC306-r AAAAGTTCTATATAATCTTATAAATTTTAATAACTAATATATAAAGATA 24 IC307-f CACAGCGGCCGCTTrTACCTCCTAACCTATAAAATTAGCC 25 IC308-r CACACATATGACCCTCCCAATACATTTAAAATAATTATGTATTCATGAAA 26 IC309-f GGCCGGTCTCTTAATAACTAATATATAAAGATATTTCTTTAAAATATTCTTATATTTAGA 27 IC310-r CCGCGGCCGCTAATTTAGATATTAATTCTAAATTAAGTGAAATTAATATAGTAATTAT 28 IC311-f GGCCGGCCGGTCTCTATTATATAAGATTATAAGAAACATTATAACATATTTTAG 29 IC312-f GGCCGGCCGGTCTCTATTAGATTATAAGAAACATTATAACATATTTTAGAACTT 30 IC313-f GGCCGGCCGGTCTCTATTATAAGAAACATTATAACATATTTTAGAACTTTTTAA 31 IC314-f GGCCGGCCGGTCTCTATTAAACATTATAACATATTTTAGAACTTTTTAACTATT 32 IC315-f GGCCGGCCGGTCTCTATTATATAACATATTTTAGAACTTTTTAACTATTCTAAA 33 IC316-f GGCCGGCCGGTCTCTATTAACATATTTTAGAACTTTTTAACTATTCTAAAAGATT 34 IC317-f GGCCGGCCGGTCTCTATTATTTTAGAACTTTTTAACTATTCTAAAAGATTAATTT 35 IC318-f GGCCGGCCGGTCTCTATTAGAACTTTTTAACTATTCTAAAAGATTAATTTACATA 36 IC319-f GGCCGGCCGGTCTCTATTATTTTAACTATTCTAAAAGATTAATTTACATATTAAC 37 IC320-f GGCCGGCCGGTCTCTATTAACTATTCTAAAAGATTAATTTACATATTAACATTTA 38 IC321-f GGCCGGCCGGTCTCTATTATCTAAAAGATTAATTTACATATTAACATTTAATTAT 39 IC322-f GGCCGGCCGGTCTCTATTATTTAATATAAGATTATAAGAAACATTATAACATATTTTAGAAC 40 IC323-f GGCCGGCCGGTCTCTATTAAAATTATATTGATTATAAGAAACATTATAACATATTTTAGAACTTTTT 41 IC324-f GGCCGGCCGGTCTCTATTAAAATTTATAACTAATTAAGAAACATTATAACATATTTTAGAACTTTTTACTATT 42 IC325-f GGCCGGCCGGTCTCTATTAAAATTTATAAGATTAATTCTAACATTATAACATATTTTAGAACTTTTTAACTATT 43 IC326-f GGCCGGCCGGTCTCTATTAAAATTTATAAGATTATAAGATTGTATATAACATATTTTAGAACTTTTTAACTATT 44 IC327-f GGCCGGCCGGTCTCTATTAAAATTTATAAGATTATAAGAAACATATATTCATATTTTAGAACTTTTTAACTATT 45 IC328-f GGCCGGCCGGTCTCTATTAAAATTTATAAGATTATAAGAAACATTATAAGTATATTTAGAACTTTTTAACTATT 46 IC329-f GGCCGGCCGGTCTCTATTAAAATTTATAAGATTATAAGAAACATTATAACATATAAATCAACTTTTTAACTATT CTAAAAG 47 IC330-f GGCCGGCCGGTCTCTATTAAAATTTATAAGATTATAAGAAACATTATAACATATTTTAGTTGAATTTAACTATT CTAAAAGATTAATT 48 IC331-f GGCCGGCCGGTCTCTATTAAAATTTATAAGATTATAAGAAACATTATAACATATTTTAGAACTTAAATTCTATT CTAAAAGATTAATTTACA 49 IC332-f GGCCGGCCGGTCTCTATTAAAATTTATAAGATTATAAGAAACATTATAACATATTTTAGAACTTTTTAAGATAA CTAAAAGATTAATTTACA 50 IC011-r TTATATACTTGGTTTATTTACTTGATTATTTCTGTAA 51 IC012-f TATTGTATAGCTTGGTATCATCT 52 IC101-f ATATGCGGCCGCGTGTAGTAGCCTGTGAAATAAGTAA 53 IC102-r ATATGGTGTCACCATTAACACACCTCCTTAAAAATTACAC 54 IC103-f TATAGGTCTCAATGGTATTTGAAAAAAT 55 IC104-r TATACTCGAGTTAACTATTTATCAATTCCTG 56 IC105-f CAGCGGCCGCATGGTATTTGAAAAAATTGATAAAAA 57 IC106-r GGCGGTACCGATTTATATTTTACCATGTTTTTATTAATTT 58 IC107-f CCCGGTACCAATACGACTCACTATAGGTTCCGGTGATACCAGCATCGTCTTGATGCCCTTG 59 IC108-r CCGGTCTCACCATGTTGTTGCCTCCTTAGCAGGGTGCTGCCAAGGGCATCAAGACGATGCT 60 IC109-r CCGGTCTCACCATGTTGTTGCCTCCTTAGCAGGGTGCTGCCAAGGGCATCAAGACGATGCT 61 IC110-r CCGGTCTCACCATCTTGTTGTTACCTCCTTAGCAGGGTGCTGCCAAGGGCATCAAGACGATGC 62 IC111-r CCGGTCTCACCATGTTGTTACCTCCTTAGCAGGGTGCTGCCAAGGGCATCAAGACGATG 63 IC112-r CCGGTCTCACCATTAAGTTACCTCCTTAGCAGGGTGCTGCCAAGGGCATCAAGACGATGC 64 IC113-r CCGGTCTCACCATTAACACACCTCCTTAGCAGGGTGCTGCCAAGGGCATCAAGACGATGC 65 IC114-r CCGGTCTCACCATCTTGTTGACCTCCTTAGCAGGGTGCTGCCAAGGGCATCAAGACGATGC 66 IC115-r CCGGTCTCACCATTGGTCGTACACTCCCTTAGCAGGGTGCTGCCAAGGGCATCAAGACGATGC 67 IC116-r CCCGGTCTCTATTGAAAAATTACACAACTTTATACGATTTAT 68 IC117-f GGTCTCACAATACGACTCACTATAGGTGATACCAGCATCGTCTTGATGCCCTTG 69 IC118-f AAACTTAACTTCATGTTAAAAACTTGTTAAAATATAAATCGTATAAAGTTGTGTAATTT 70 IC119-r ATTTATATTTTAACAAGTTTTTAACATGAAGTTAAGTTTTTTTTATATAACTGTATAACC 71 IC263-r AAATGTGAAATCCGTCACATACT 72 IC264-r GGTATCATCTCATCATATATCCCCAATTCACCATCTT 73 IC265-r TATAGGCGCGCCTTTACAATCATTGCAATATAATAAAG 74 M13-f TGTAAAACGACGGCCAGT 75 M13-r CAGGAAACAGCTATGACC 76 IC333-r CCGGTCTCAATGCAAATATTGTGGAAAAAGTATGTTAAAGA 77 IC334-r CCGGTCTCTGCATCTTGTTGTTACCTCCTTAGCAGGGTGCTGCCAAGGGCATCAAGACGATGC 78 IC335-r CCGGTCTCTGCATTAAGTTACCTCCTTAGCAGGGTGCTGCCAAGGGCATCAAGACGATGC 79 IC336-r CCGGTCTCTGCATTAACACACCTCCTTAGCAGGGTGCTGCCAAGGGCATCAAGACGATGC 80 IC337-f GGCGGTACCGAGCTTTGCAAAGCAGTTTATCAACATAAA 81 IC338-f GGCGGTACCTATAAAATTAGCCAATTTTATAGTAGTCTT 82 IC339-f GCCCCCTGCAGGAGTAATATAAATGTTATAGATATATTAA 83 IC340-r CCGGTCTCAAACCTTATTTTTGTTCTCTACTACCTGGTTTTACAAA 84 IC341-f CCCGGGTCTCAGGTTTCCCGACTGGAAAGCGGGCAGTGACCAGGCATCAAATAAAACGAAAGGCTCAGTCGAAA GACTGGGCCTTTCGTTTTATCTGTTGTTTGTCGGTGAACGCTCTCT 85 IC342-r CCCGCGGCCGCAGTTAATTATTGATTATAAACGCAGAAAGGCCCACCCGAAGGTGAGCCAGTGTGACTCTAGTA GAGAGCGTTCACCGACAAACAACAGATAAAACGAAAGGCCCA 86 IC343-r GGCCGGTCTCAATTGATACATTTAAAATAATTATGTATTCATGAAACATGATTGT 87 IC011-r TTATATACTTGGTTTATTTACTTGATTATTTCTGTAA 88 IC012-f TATTGTATAGCTTGGTATCATCT 89 IC001-f GAAGACTTAGAAAATTATATGAAAGAAGAAGGT 90 IC002-r CAAAAGCACTTGAAAATGCATG
[0163] Having established the functionality of the LAC system, further experiments were undertaken to determine the kinetics of induction, specifically, the time that is required for the system to respond to a change in lactose levels as well as the time-course of induction. Accordingly, C. sporogenes cells harbouring the plasmid pMTL-HZ1, were cultivated in TYG medium in the presence and absence of 10 mM lactose and their optical density (OD600) monitored over time (
[0164] Expression of catP above the level of the uninduced culture was detectable immediately upon addition of lactose (at 4 hours), supporting the notion that induction occurs within a few minutes of lactose being added. In agreement with the results obtained by Hartman and colleagues, these data indicate that lactose, and not a derivate, is the metabolite that activates gene expression in C. sporogenes. Activation of gene expression would have not been possible immediately after induction in the case of a lactose derivative, since, generally, some time is required to express the enzymes required for the metabolite conversion and for the conversion itself.
[0165] Maximum CAT activity was observed at 8 hours. The levels of reporter began to decrease after 10 hours and had been reduced by approximately 15% after 24 hours. Since no differences in growth rates were observable between the cells grown in the presence and absence of lactose, the observed reduction in expression was not a consequence of a decrease in growth rate caused by the addition of inducer. It is known that the availability of the cell's transcriptional and translational machineries is growth-rate dependent, a factor that can affect gene expression. In particular, this dependency is more pronounced in the case of positive regulation mediated by constitutively expressed activators, since the expression of the activator itself—required to activate the expression of the target gene—is already growth-rate dependant. Basal CAT expression in the absence of the inducer slightly increased with time, which is indicative of the leaky transcription from PbgaR and/or PbgaL.
[0166] The LAC system was shown to be functional in C. sporogenes. However, for applications where very tight control of gene expression is required (i.e., to control sporulation), the system remains far from ideal. Of the inducible systems available for Clostridium, only the TET system exhibits very low basal expression while maintaining a high induction efficiency. Nevertheless, the optimal working conditions of the TET system require high doses of the inducer anhydrotetracycline, a tetracycline-analogue. The levels required, however, have significant inhibitory effects on cell growth. Thus, it seemed necessary to obtain (or develop) a more tightly regulated inducible system for Clostridium that does not rely on any antibiotic and is suitable for any potential application.
[0167] The strategy adopted in this invention was to synthetically optimize an inducible system, and studies were undertaken to further characterise the LAC system.
Further Characterization of the LAC System
[0168] During transcription initiation, RNAP and one or more transcriptional initiation factors bind to the promoter sequence via sequence-specific interactions to form an RNAP-promoter open complex, initiating transcription at the TSS. Although the distance between the TSS and the promoter core elements can vary, there is a general preference for TSS selection at a position 7 bp downstream of the promoter −10 element. Although there are several tools for predicting promoters available, the vast majority rely on sequence databases from model organisms, such as E. coli, and are not yet very efficient for non-model chassis like Clostridium. Thus, accurate TSS location makes determination of promoters more accurate.
[0169] In order to determine the TSS of the promoters involved in the functioning of the LAC system, the approach 5′ RACE, was used. This technique allows the synthesis of cDNA from a specific mRNA target. A polyAtail, termed adaptor, is then added to the 5′ end of the cDNA, which allows further amplification and determination of the sequence of the 5′ UTR. Analysis of the bgaR promoter required a new reporter vector containing PbgaR upstream of the catP reporter, termed pMTL-IC1201. As with previous reporter constructs, it is based on the pMTL82251 chassis. The general LAC reporter vector, pMTL-HZ1, was used to determine the TSS of PbgaL. Total RNA was extracted from stationary cultures of C. sporogenes harbouring the designated constructs and 5′ RACE was performed using catP specific primers for the cDNA reverse transcription and extension steps (
[0170] Sequencing of the PCR products resulted in 5′ UTR sequences with the TSS located 66 and 109 nucleotides upstream of the translation start site (ATG) of PbgaR and PbgaL, respectively. It has to be noted that one limitation of the 5′ RACE procedure is the inaccurate determination of the TSS of mRNAs ending with one or several thiamine residues, since during 5′ RACE a poly-A tail adaptor is added to the cDNA 3′ end (complementary to the 5′ UTR in the mRNA). Therefore, discrimination between a thiamine residue belonging to either the original 5′ UTR sequence, or to the anchor primer that binds to the poly-A adaptor, is impossible. Following the rule of the 7 bp upstream of the TSS, and based on the consensus 17-bp spacer between the −10 and −35 regulatory elements, the putative −10 and −35 boxes were manually annotated. It is worth noting that, despite the determination of the putative −10 and −35 elements being possibly accurate, they can only be approximations, since the analysis of the importance of every nucleotide residue nearby would be required for an exact determination.
[0171] Regulation of gene expression in response to inducing ligands (i.e., lactose) is mainly mediated by TFs. These interact with conserved cis-acting elements, or operator motifs, that are located in close proximity to or within the promoter sequence of genes involved with the metabolism of the inducer. Since bgaR encodes the TF that activates gene expression in the LAC system, the operator sequence/s linked to this regulation should be situated in close proximity to the annotated regulatory elements of PbgaL. One simple approach to identify regulatory elements within the promoters of regulated genes is to compare sequences from divergent species. By multiple alignment, conserved elements can be distinguished from sequences that have evolved more rapidly. Accordingly, an approach to predict TF-specific motifs, previously reported by Francke and colleagues, but applied to a different family of TFs, was chosen. The main premise behind this approach is that equivalent regulatory sites will be shared only if orthologous sequences share genomic context. In this sense, synteny—conserved gene order—was considered to strongly indicate functional equivalency. Thus, only TFs divergently oriented in relation to the regulated gene were considered in this study. Since BgaR (accession number WP_003480500), is classified as an AraC/XylS-famly of TFs, a total of 71 non-redundant AraC/XylS-family TFs from taxonomically related Firmicutegenomes were aligned and grouped through a Neighbor Joining algorithm using the program MEGA version 6 (
[0172] The 300 bp upstream of the most phylogenetically related sequences (highlighted in black) were used to identify consensus motifs using the program MEME. As a result, two consensus motifs of 20 bp in length, termed O1 and O2, were identified as hypothetical regulatory elements of the LAC system (
[0173] Following the identification of O1 and O2 as hypothetical operator sequences, 3 new constructs were designed in which either O1 or O2 and both O1 and O2 had been deleted, generating vectors pMTIL-ICMO1, pMTL-ICMO2 and pMTL-ICMO102, respectively. Additionally, a construct lacking bgaR, termed pMTL-ICMB, was also created, which served to determine to what extent activation of gene expression depended on the presence of BgaR.
[0174] The CAT data shown in
[0175] Having established that O2 might be involved in PbgaL activation, further investigations of the importance of the DNA sequence around this motif were pursued via mutational analysis. At this point, it was considered that O2 is not part of the main regulatory elements of PbgaL (−10 and −35 elements), since O2 is located at a distance of 59 bp from the TSS downstream of PbgaL (between positions −72 and −52). Several pMTL-HZL1-derived mutant plasmids with truncated or mutated sequences located upstream of the TSS were therefore generated employing a previously reported mutagenesis strategy; PbgaL activity was quantified by determining levels of CAT activity in lysates of plasmid carrying C. sporogenes strains. A total of eleven truncated variants were constructed, termed pMTL-ICT1 to −T11, by sequentially deleting five nucleotides between positions −89 and −34 (where the −35 element resides) (
[0176] Truncations downstream of position −69 (pMTL-ICT5), within the 5′ sequence of PbgaL caused a strong decrease in promoter activity from position −69 pMTI-ICT5). In particular, deletions downstream of position −64 (pMTL-ICT6) resulted in the same level of gene expression previously observed when deleting the consensus motif O2 or the transcriptional factor bgaR, which corresponds to the background expression of PbgaL. Additionally, substitutions of 5 bp length within the same region provided extra information. Mutations between positions −89 and −74 did not have a significant effect on PbgaL activity, relative to the native system. Substitutions between positions −74 and −69 slightly decreased gene expression (pMTL-ICM4), whereas those occurring between positions −69 and −44 had a more severe effect on PbgaL expression. In some cases, such as in the substitutions between positions −69 to −64 and −59 to −54, corresponding to vectors pMTL-ICM5 and pMTL-ICM7, respectively, gene expression was almost abolished. Interestingly, substitutions between the positions −44 and −39 did not have any effect on PbgaL expression (pMTL-ICM10), whereas the five nucleotide substitution immediately after this (between positions −39 and −34, pMTL-1CM 11) resulted in a level of gene expression comparable to the background. This result supports the validity of the previously determined position of the putative −35 element, which is partially deleted in pMTL-ICM11. This finding also agrees with O1 being a conserved consensus motif—the −35 element—of the sequences previously analysed.
[0177] The data presented here provides a general outline of the mechanisms behind the LAC system from C. perfringens strain 13, and allowed the generation of a synthetic system with both reduced background expression and large dynamic range.
Example 2—Theophylline-Responsive Translational Riboswitches in Clostridium
[0178] In this Example, it is shown that previously existing, as well as newly designed theophylline-dependent riboswitches, function in C. sporogenes with a response that is dependent on inducer concentration.
Theophylline Responsive Riboswitches for Clostridium
[0179] As previous work had shown that many diverse theophylline-dependent riboswitches were functional in both Gram-positive and Gram-negative bacteria, it was decided to evaluate the performance of this inducible translational regulatory system in C. sporogenes NCIMB 10696. Accordingly, three riboswitch sequences, riboswitch-D, -E and -E*, which were expected to exhibit higher translation efficiencies after induction, out of the six theophylline responsive riboswitches developed by Gallivan and coworkers were selected. In previous publications, riboswitch-E* was shown to be the best theophylline-dependant riboregulator in Gram-positive bacteria, thanks to its high dynamic range and its very low basal expression. In the present study, 4 new riboswitches (named -F to -I) were constructed by rationally modifying the space between the SD sequence and the translational start site of the original riboswitch-E* (Table 4).
TABLE-US-00011 TABLE 4 Nucleotide sequences of the riboswitches used in this study. The aptamer sequence is underlined. The translational start is bold and italicised. Modifications of the parent riboswitch-E* are indicated in red, Rational modifications were based on known strong RBS sequences in the genus Clostridium. SEQ ID NO. Riboswitch Sequence (5′ 3′) 4 E GGUGAUACCAGCAUCGUCUUGAUGCCCUUGGCA GCACCCUGCUAAGGAGGUAACAACAAG
7 G GGUGAUACCAGCAUCGUCUUGAUGCCCUUGGCA GCACCCUGCUAAGGAGGUAACUUA
8 H GGUGAUACCAGCAUCGUCUUGAUGCCCUUGGCA GCACCCUGCUAAGGAGGUGUGUUA
[0180] A reporter plasmid, pMTL-IC101, derived from the vector pMTL82251, was used as a chassis for all of the subsequently created plasmids (
[0181] As a default, the riboswitches, preceded by a linker sequence, were genetically fused to the core region (−35 and −10) of the strong Pfdx. just downstream of the TSS and excluding the native 5′ UTR sequence, as previously described 187. The sequence comprising the promoter-riboswitch-reporter was then cloned into the aforementioned reporter chassis.
[0182] In order to place the riboswitch sequences downstream of the TSS of Pfdx, the TSS of Pfdx had to be determined. To this end, the 5′ RACE procedure described in Example 1 was used. Total RNA was extracted from stationary cultures of C. sporogenes harbouring the reporter plasmid pMTL-IC101 and 5′ RACE was performed using the same catP specific primers described in Example 1. As a result, the amplification of the 5′ UTR sequence downstream of Pfdx was successfully obtained (
[0183] Plasmid constructs, designated pMTL-IC111-D to -J, were conjugated into C. sporogenes and cultures of the resultant transconjugant cells exposed to 2 mM theophylline inducer when they had reached the early exponential phase of growth (OD600≈0.5). CAT activity was determined in cell lysates derived from stationary phase cultures cultivated in the presence or absence of the inducer (
Adjustability of the Theophylline Responsive Riboswitches
[0184] Due to the importance of having inducible systems where gene expression can be controlled within a large regulatory window, it was decided to compare the expression pattern of riboswitches -E, -G and -H when placed downstream of the core region of a synthetically weakened Pfdx, named Pfdx4, creating vectors pMTL-IC201-E, -G and -H. The promoter Pfdx4 was generated by replacing the core elements −10 and −35 of Pfdx with the same regulatory elements of the constitutive promoter from the C. acetobutylicum ATCC 824 ptb gene (Pptb, associated with the protein coding gene Ca_3076) (
[0185] As shown in
Functional Characterization of the Theophylline Responsive Riboswitch in C. sporogenes NCIMB 10696
[0186] To assess the dose dependency of riboswitch regulation, strains harbouring plasmids that carried the riboswitch-G downstream of Pfdx or Pfdx* were cultivated with increasing concentrations of theophylline, ranging from 0.1 to 10 mM (
[0187] As with lactose in Example 1, it was decided to establish whether theophylline is metabolized by C. sporogenes. C. sporogenes cells were, therefore, cultivated in TYG medium supplemented with 2 mM theophylline and the concentration of theophylline was monitored by HPLC/MS analysis of cell free supernatant samples over time. Results showed that the concentration of theophylline remained constant over the course of the experiment, with a slight increase in the culture supernatant 20 hours after induction, possibly due to the release of the inducer from the cells after lysis (
[0188] Altogether, these data demonstrate that the theophylline responsive riboswitches function in C. sporogenes with a response that is dependent on inducer concentration. In particular, the rationally designed riboswitch-G outperformed previously published riboswitches, exhibiting very low basal expression and the largest dynamic range. The regulatory window of the theophylline responsive riboswitches could be adjusted by modifying the 5′ UTR sequence located upstream of the riboswitch or by using promoters with different strengths. However, the incorporation of any riboswitch in the 5′ UTR led to a strong reduction in reporter activity in all cases, with higher levels of gene expression linked to increased leakiness in the absence of the inducer. This, in fact, compromised the dynamic range of the riboregulators. In all cases, the riboswitch was able to respond to the inducer theophylline, ensuring its performance independent of the genetic context. Additionally, because C. sporogenes does not degrade theophylline, this is confirmed, thus far, as an appropriate inducer for further applications.
Example 3—A Dual Mechanism to Tightly Control Gene Expression (Ribolac)
[0189] Having established the limitations of the existing transcriptional inducible systems to tightly control gene expression in Clostridium, it was decided to engineer a system with improved characteristics so that high levels of gene expression do not compromise the dynamic range. By combining the theophylline responsive riboswitch with the transcriptionally regulated LAC system from C. perfringens strain 13, a dual translational-transcriptional ON device that controls the expression of both, bgaR and the gene of interest, was generated. In this system, termed RiboLac, optimal expression of the target gene requires induction with both theophylline and lactose.
RiboLac, a Dual Mechanism with Improved Dynamic Range
[0190] In Example 1, it was demonstrated that the LAC system requires BgaR to activate gene expression. It was also shown that background expression was reduced by 50% if the system lacks BgaR, providing a clue as to how leaky expression could potentially be reduced in this inducible system. Additionally, some of the riboswitches characterized above, in particular riboswitches -E, -G and -H, demonstrated tight control of gene expression in the OFF state, exhibiting diverse expression profiles upon activation. By combining these two types of regulation, it was hypothesized that a system with translational control over bgaR and transcriptional control over the target gene (catP) could be generated, in which expression was subject to the addition of two inducers, lactose and theophylline. Since the amount of BgaR required to activate gene expression in native inducible system was unknown, it was decided to generate several systems that would lead to various levels of BgaR in both the ON and OFF states. It was expected that one of the systems would allow an adequate expression of BgaR in the presence and absence of the inducer, successfully facilitating controlled activation of PbgaL. Accordingly, three riboswitch sequences, riboswitch-E, -G and -H, were genetically fused to the core region (−35 and −10) of the bgaR promoter, PbgaR, just downstream of the TSS (determined in Example 1) and excluding the native 5′UTR, generating vectors pMTL-ICE1, pMTL-ICG1 and pMTL-ICH1. The rest of the system remained as it was in the parent LAC reporter vector pMTL-HZ1. Additionally, the same riboswitches were placed downstream of PbgaR*, which retains the bases downstream of the TSS but excludes the native SD sequence, as described in Example 2, generating the vectors pMTL-ICE1*, pMTL-ICG1* and pMTLICH1*. Constructs, which contained the reporter gene catP, were conjugated into C. sporogenes and growing cultures of the transconjugants obtained were exposed to either one of the inducers—theophylline or lactose—to both inducers, or grown without induction.
[0191] The CAT data shown in
Functional Characterization of the RiboLac
[0192] Having established the functionality of the RiboLac, further experiments were undertaken to determine the dynamics of induction; specifically, the activation of PbgaL when bgaR expression is induced with various concentrations of theophylline. Accordingly, strains harbouring the plasmids pMTL-HZ1 and pMTL-ICG1* were cultivated with increasing concentrations of theophylline ranging from 0 to 2 mM, in the presence and absence of 10 mM lactose (
[0193] Additionally, the RiboLac was also analysed for CAT expression over time in the absence of inducers and at the highest concentrations of inducers tested. In the previous theophylline-dependency assay, maximum induction was obtained with 0.5 mM theophylline and 10 mM lactose. However, in Example 2, maximum induction of the theophylline responsive riboswitches, without affecting cell growth, was obtained with 2 mM theophylline. As a matter of consistency, 2 mM theophylline was used to obtain maximum levels of expression in the RiboLac as well. Accordingly, CAT expression of cultures grown in the presence and absence of 2 mM theophylline and 10 mM lactose, as well as their optical density (OD600), were monitored over time (
[0194] In both systems, expression of catP above the level of the uninduced culture was detectable immediately upon addition of the inducers (at 4 hours), indicating that expression of BgaR under the control of the riboswitch occurs within a few minutes of theophylline being added. No significant differences in CAT expression were observed between the LAC system and the RiboLac in the presence of inducers. However, whilst CAT expression in the absence of inducer slightly increased with time in cultures harbouring the LAC system, from six hours onwards, it decreased in cultures harbouring the RiboLac. Maximum expression under the control of the theophylline responsive riboswitch studied in Example 2 was reached between 4 and 6 hours post induction (8-10 hours of growth), with expression after 20 hours reduced by 75% and 40% in Pfdx and Pfdx*, respectively. Accordingly, reversal of background expression in the RiboLac over time might be associated with the abundance or stability of the mRNA encoding BgaR, which is strongly reduced between 4 and 6 hours after induction. No differences in growth rates were observed between the cells grown in the presence and absence of the inducers.
The RiboLac in the Chromosome
[0195] The engineering of plasmid-free stable strains requires that the biological parts conferring the desired functionality are integrated into the host genome. To determine whether the degree of repression and dynamic range would provide suitable levels of gene expression under these conditions, the RiboLac was integrated into the clostridial host chromosome. When this study initiated, chromosomal integration into clostridial genomes was achieved via recombination-based allelic exchange. Specifically, integration of a particular cargo into the same strain of C. sporogenes used in this study had been previously been accomplished using ACE, relying on the interconversion of the pyrE locus between a functional and mutant allele. In ACE, the coupling of a plasmid specified allele with a chromosomal allele during allelic exchange results in the formation of a new allele that has a selectable phenotype. The pyrE gene encodes the enzyme orotate phosphoribosyltransferase which is involved in de novo synthesis of the pyrimidine base, uracil. Cells carrying a mutant, chromosomally located pyre allele, lacking the 3′ end of the gene, can no longer make uracil, and are unable to grow in defined media without the addition of exogenous uracil. ACE plasmids carrying a pyrE allele comprising all but the first 8 codons of the gene can be used to restore the mutant, chromosomal allele to WT through selection for uracil prototrophy. Moreover, cargo DNA inserted into the ACE plasmid immediately downstream of the pyrE allele becomes integrated into the genome concomitant with restoration of prototrophy.
[0196] To integrate RiboLac in the pyrE locus, the vector pMTL-JH29, which contains two unequally sized regions of homology to the C. sporogenes chromosome, was modified to include a double terminator immediately downstream of the pyrE gene, intended to insulate the integrated expression unit. The double terminator, composed of the E. coli rrnB T1 terminator and the phage T7 early transcription terminator, was synthesised based on the existing sequence in the registry of standard biological parts (BBa_BOO15). The terminator rrnM T1 from E. coli had been demonstrated to be functional in C. acetobutylicum, which, combined with the phage T7 early transcription terminator, is the most frequently used double terminator from the registry of standard biological parts. The integration vector containing the double terminator was renamed pMTL-JH29T. In this vector, one of the homologous regions, corresponding to the longer 1200 bp region immediately downstream of pyrE, directs the first recombination event resulting in single crossover integration of the plasmid. Subsequent plasmid excision via the second, smaller region of homology, corresponding to a pyrE allele lacking its 5′ end, results in the integration of the double terminator concomitant with restoration of uracil prototrophy. The vector includes the restriction sites NotI and XhoI between the double terminator and the longer homologous region so that a specific cargo can be easily inserted in the vector for its consequent integration. Accordingly, two vectors, pMTL-JH29T-L and pMTL-JH29T-R, were created by inserting the LAC system-catP and the RiboLac-catP coding sequences, respectively. These sequences were directly taken from the reporter vectors pMTL-HZ1 and pMTLICG1*, respectively, through restriction digestion using the restriction sites NotI and XhoI. Inserts were incorporated into the integration vector via the same restriction sites. As such, the LAC and RiboLac coding sequences also include the native terminator downstream of bgaR. The designated plasmid constructs were transferred into C. sporogenes (in triplicates) from their respective E. coli donor strains. Integrants were isolated by plating cultures of the resultant transconjugants onto defined medium lacking uracil. Integration of both the LAC system and the RiboLac reporter systems into the pyrE locus were confirmed via PCR, using external primers targeting the C. sporogenes chromosome (
[0197] In order to assess expression, cultures of the integrants obtained, named C. sporogenes::LAC and C. sporogenes::RiboLac, were cultivated in TYG medium and induced with only one of the inducers, theophylline (2 mM) or lactose (10 mM), or with both inducers (2 mM theophylline and 10 mM lactose) as well as in the absence of inducers. A control culture was included to which no inducers were added. Strains harbouring the reporter plasmids pMTL-HZ1 and pMTL-ICG1* were used as positive controls as well as to determine the differences in expression encountered between the plasmid-based systems and the same systems integrated into the clostridial chromosome.
[0198] Expression of catP driven by the integrated RiboLac was only detectable in the presence of both inducers, indicating that the dual mechanism is functional also in the chromosome of C. sporogenes (
Example 4—Development of a Conditionally Sporulating C. sporogenes Strain
[0199] In this Example, the inducible systems described above are utilized to generate conditionally sporulating strains by controlling the expression of the master regulator Spo0A. After demonstrating that plasmid based conditionally sporulating strains could be created, stable strains with inducible control of spore formation integrated into the bacterial chromosome were generated. Specifically, by addition of the inducers lactose and theophylline, the strain C. sporogenes::RiboLac-spo0A can be artificially induced to sporulate, with a sporulation capacity similar to that of the WT strain. This strain is completely asporogeneous in the absence of inducers.
Generation of an Asporogeneous Host to Test Conditional Sporulation Systems
[0200] spo0A represents one suitable target for the creation of a conditionally sporulating strain. As such, a strategy wherein the inducible systems from Examples 1 and 2 are used to regulate the expression of spo0A was considered. Since the systems exhibited various dynamic ranges, it was expected that one of them would result in a strain incapable of sporulating in the absence of induction but able to restore spore formation—ideally to WT levels—in the presence of inducer/s.
[0201] In order to generate a conditionally sporulating strain via tightly regulating the expression of the spo0A gene, a strain deficient in this gene had to be generated. Deletion of the spo0A gene (Clspo_c18650) was achieved via creating an in-frame deletion by pyrE-based allelic exchange. pyrE-based allelic exchange also requires a pyrE-deficient background. With the PyrE enzyme truncated, the organism is uracil auxotrophic and resistant to the compound 5-FOA. The selection of mutants is achieved by using a heterologous pyrE gene as a negative counter-selection marker in the presence of 5-FOA. Additionally, since the in-frame deletion is achieved in a pyrE-deficient background, complemented strains can be easily obtained using ACE whilst the pyrE allele is corrected.
[0202] The isolation of the single cross-over plasmid integrants is facilitated by “pseudo-suicide” vectors. These are plasmids that carry a selection marker (i.e., catP, encoding resistance to thiamphenicol) which are sufficiently defective in its replication so that cells carrying the non-integrated plasmid exhibit a growth disadvantage relative to cells in which the vector, containing the gene that confers resistance to the antibiotic (i.e., catP), has been integrated. As such, clones with the plasmid integrated grow faster on agar medium supplemented with thiamphenicol than cells carrying catP on a non-integrated, replication defective plasmid because if integrated growth is not limited by the rate at which the plasmid is segregated among the progeny. A vector derived from the construct pMTL-CH14, which had been previously generated by a member of this group, was used to delete the spo0A gene from the C. sporogenes pyrE- strain. The plasmid pMTL-CH14 incorporates a heterologous, functional pyrE gene from C. acetobutylicum and the C. difficile pCD6 replicon. Since the origin of replication from the Bacillus plasmid pIM13 was shown to be more appropriate for the isolation of faster-growing single-colonies in the same strain of C. sporogenes, the pCD6 replicon was replaced by the pIM13 replicon in pMTL-CH14, generating the deletion vector pMTL-ICD. The spo0A knockout cluster, comprising two equal 1000 bp homologous regions upstream and downstream of spo0A, respectively, was generated by SOEing PCR and inserted into the deletion vector. The deletion vector, termed pMTL-ICD-spo0A, was transferred into C. sporogenes (in triplicates) from its respective E. coli donor by conjugative plasmid transfer; transconjugant cells were screened for plasmid integration by colony PCR (
[0203] Successful single-cross mutants derived from three independent conjugations—all obtained by homologous recombination through the left homologous regions (LHR)—were streaked onto TYG medium supplemented with 5-FOA; deletion of the spo0A gene was confirmed via colony PCR from S-FOA-resistant colonies, using primers aligning outside of the crossover region (
spo0A Complementation and pyrE Repair
[0204] In order to confirm that the phenotype observed in the mutant strain is directly attributable to the deletion of spo0A, a spo0A complemented strain was generated via ACE, incorporating spo0A under the control of its own promoter downstream of the repaired pyrE locus. The integration plasmid pMTL-JH29-spo0A, carrying spo0A flanked by its native promoter and terminator, was conjugated into C. sporogenes Δspo0A pyrE- and integrants were isolated by plating cultures of the resultant transconjugants onto defined medium lacking. The complemented strain was named C. sporogenes Δspo0ACOMP. Additionally, in order to fairly compare the spo0A mutant with the complemented strain, which contains a functional pyrE gene after being complemented with spo0A in the pyrE locus, a strain lacking spo0A but with a functional pyrE gene was also created. Accordingly, the “empty” pMTL-JH29 vector (with no integration cargo) was used in a similar fashion to restore the full-length of the pyrE gene, generating C. sporogenes Δspo0A.
Characterization of C. sporogenes Δspo0A pyrE-
[0205] C. sporogenes Δspo0A pyrE-, the strain which would serve as a host to create a conditionally sporulating strain, was characterized for both its sporulation capacity and growth profile. Accordingly, the spo0A complemented strain, C. sporogenes Δspo0ACOMP was used to evaluate if the deletion of spo0A is the cause of the expected asporogeneous phenotype. The spo0A mutant with regained uracil autotrophy, C. sporogenes Δspo0A, was included in the assay to account for any effect pyrE could have on spore formation and growth. C. sporogenes WT and C. sporogenes pyrE- were used as positive controls. Detection of heat resistant spores follows a simple procedure of heat-shocking cell suspensions at 80° C. for 20 minutes; CFUs are obtained from plating serial dilutions of such suspensions on appropriate nutrient agar plates. Accordingly, synchronized cultures of the designated strains were cultivated in TYG medium and total and heat-resistant CFU were enumerated at 24 hour intervals for five days (
[0206] As anticipated, none of the spo0A mutants, pyrE- and pyrE-repaired, were able to form spores over the course of the experiment; in both cases, total CFU was significantly lower than in the strains containing spo0A (approximately 10-fold) (unpaired two-tailed Student's t-test, *p≤40.0332 in both cases), indicative of the role Spo0A plays in cell viability. Moreover, a slight decrease in cell density was observed after 24 hours of growth in strains lacking spo0A. This would be in line with the notion that a mechanism (i.e., phosphorelay in B. subtilis), at the centre of which is Spo0A, integrates nutritional, cell density and other signals to initiate the sporulation process 226. The complemented strain, C. sporogenes Δspo0ACOMP, was able to sporulate; however, its sporulation capacity was reduced by approximately 10-fold at all time points when compared to the spo0A-positive strains.
Plasmid-Based Conditionally Sporulating Strains
[0207] Having generated the strain of C. sporogenes required to test if the inducible expression of spo0A would result in the conditional control of spore formation, it was decided, initially, to evaluate the sporulation capacity of C. sporogenes Δspo0A strains harbouring plasmids where spo0A expression was regulated by the inducible systems developed in the previous Examples; these are: theophylline responsive riboswitches, the LAC system from C. perfringens strain 13 and the RiboLac.
[0208] To facilitate comparisons of the results obtained in the sporulation assays and to estimate how the reported strengths and dynamic ranges of the inducible systems relate to spore formation when controlling spo0A expression, CAT assays to monitor inducible promoter activities using all the systems generated in the Examples were carried out (
[0209] For assessing sporulation, the backbone pMTL82251 used in the previous Examples was also considered as a backbone for all the spo0A expressing plasmids. All vectors were assembled in an identical fashion to the CAT reporter plasmids, but with spo0A as the target gene instead of catP. The series of spo0A expressing plasmids, termed pMTL-ICSPO followed by the name of the regulatory system (e.g., pMTL-ICSPO-Pfdx4-E for the vector expressing spo0A under the control of PJdx4 located upstream of riboswitch-E), were conjugated into C. sporogenes Δspo0A from their respective E. coli donors. Cultures of the resultant transconjugants were analysed for heat resistant spore production after 120 hours of nutrient starvation in liquid culture, in the presence and absence of the inducer/s. This is normally considered as the time after which the sporulation process in most of the cells of a C. sporogenes culture has been completed 228. C. sporogenes WT and C. sporogenes Δspo0A were used as positive and negative controls, respectively.
[0210] Results from
Chromosomally Stable Conditionally Sporulating Strains
[0211] Progression towards a stable strain capable of conditionally forming spores required the integration of spo0A, driven by an inducible system, into the chromosome of the clostridial host. Given that the level of repression and dynamic range of the different inducible systems regulating spo0A once integrated into the chromosome was unknown, it was decided to integrate several systems so that a wide range of expression profiles was covered. These included the two systems that were able to repress spore formation in the plasmid-based sporulating strains (i.e., Pfdx4-E and Pfdx4*-E); the promoters Pfdx, Pfdx* and ParaE* located upstream of the riboswitches -E and -G; the LAC system, and; the RiboLac. Although riboswitches -E and -G resulted in similar levels of plasmid-based spore counts in the presence and absence of the inducer, it was expected that expression from the single copy chromosome would result in observable differences, which could translate into a different profile of spore formation.
[0212] All inducible system-spo0A sequences were ligated into pMTL-JH29T and integrated into the genome of C. sporogenes at the pyrE locus, as previously described, and the sporulation capacity of the resultant mutants analysed. Accordingly, synchronized cultures of the designated strains were cultivated in TGY medium, in the presence and absence of induction, and total and heat-resistant CFU were enumerated after 120 hours of growth (
[0213] Analysis of the sporulation capacity of strains containing spo0A driven by an inducible system integrated into the chromosome revealed one conditionally sporulating strain with a tight regulation of spore formation, resulting in no spores in the absence of the inducer and spore counts comparable to those of the WT strain after induction. This system was the RiboLac. Surprisingly, only the strong ParaE* promoter, out of all the integrated theophylline responsive riboswitches, was able to express spo0A, after induction, to an extent that cells were capable of activating the sporulation program; however, sporulation capacity was reduced by 10.sup.4-fold and 10.sup.6-fold relative to the WT strain, when regulated by riboswitches -E and -G, respectively. The rest of the strains with spo0A controlled by a riboswitch did not sporulate, either in the absence or in the presence of induction. Since these systems exhibited various levels of catP expression and induction profiles in previous assays (
Characterization of the Stable Conditionally Sporulating C. Sporogenes::Ribolac-spo0A Strain
[0214] The data obtained had demonstrated that the RiboLac is sufficiently tightly regulated to generate, after 120 hours, an asporogeneous strain when grown in the absence of inducers, and capable of forming spores in a WT fashion when cultivated at maximum induction (2 mM theophylline and 10 mM lactose). It was, therefore, of interest to investigate how changes in Spo0A levels, obtained via induction with various concentrations of inducers, would affect the overall sporulation efficiency (
[0215] Once the dose-dependent sporulation profile of C. sporogenes::RiboLac-spo0A was determined, it was decided to investigate if the induction of spo0A had any effect on the dynamics of the sporulation process. Accordingly, spore production was monitored over time with three different concentrations of inducers, chosen on the basis of the range of spore counts obtained in the dose-dependency assay: 0 mM theophylline and 0 mM lactose (no sporulation); 0.1 mM theophylline and 10 mM lactose (medium induction), and; 2 mM theophylline and 10 mM lactose (maximum induction) (